Literature DB >> 28331478

Current Research and Management of Hepatopulmonary Syndrome.

Michael B Fallon1.   

Abstract

Entities:  

Year:  2006        PMID： 28331478      PMCID： PMC5359935     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Pulmonary-Hepatic vascular Disorders (PHD).

Authors:  R Rodríguez-Roisin; M J Krowka; Ph Hervé; M B Fallon
Journal:  Eur Respir J       Date:  2004-11       Impact factor: 16.671

2.  Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients.

Authors:  E Schiffer; P Majno; G Mentha; E Giostra; H Burri; C E Klopfenstein; M Beaussier; P Morel; A Hadengue; C M Pastor
Journal:  Am J Transplant       Date:  2006-06       Impact factor: 8.086

3.  Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome.

Authors:  Graciela Martinez-Palli; Britt B Drake; Joan-Carles Garcia-Pagan; Joan-Albert Barbera; Miguel R Arguedas; Robert Rodriguez-Roisin; Jaume Bosch; Michael B Fallon
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

4.  Hepatopulmonary syndrome.

Authors:  Miguel R Arguedas; Michael B Fallon
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

5.  Pentoxyphylline and propentophylline are inhibitors of TNF-alpha release in monocytes activated by advanced glycation endproducts.

Authors:  I Meiners; S Hauschildt; K Nieber; G Münch
Journal:  J Neural Transm (Vienna)       Date:  2003-12-03       Impact factor: 3.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.